Dsm-firmenich slips as slight Q3 beat, guidance hike 'not enough'

By Reuters News

** Shares in dsm-firmenich DSFIR.AS fall about 4%, analysts point out the Dutch ingredients maker's slight Q3 beat and FY growth outlook hike are "not enough"

** Dsm-firmenich reports Q3 adjusted EBITDA of €482 million ($541.29 million), slightly above a company-provided consensus of €478 million; it forecasts FY growth of around 5%, up from previous 2-4%

** "Is 5% enough?" Jefferies asks, expecting post-results share price pressure

** "The stock is up ~10% over the past month, suggesting expectations have moved higher; as such, an in-line print may not be enough today," J.P. Morgan says

** JPM sees implied Q4 organic sales growth of about 5% as "reassuring", but Q3-Q4 seasonality points to Q4 adjusted EBITDA in line with or slightly below consensus

($1 = 0.8905 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk